ADMA Biologics Inc (ADMA)

Operating profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating income	US$ in thousands	138,983	21,632	-39,365	-58,374	-64,915
Revenue	US$ in thousands	426,454	258,215	154,080	80,943	42,220
Operating profit margin		32.59%	8.38%	-25.55%	-72.12%	-153.75%

December 31, 2024 calculation

Operating profit margin = Operating income ÷ Revenue
= $138,983K ÷ $426,454K
= 32.59%

Based on the data provided for ADMA Biologics Inc, the operating profit margin has shown significant fluctuations over the years:

- December 31, 2020: The operating profit margin was at a concerning -153.75%, indicating that the company's operating expenses exceeded its revenues by a substantial margin.
- December 31, 2021: The operating profit margin improved to -72.12%, suggesting that the company's cost management may have become more effective, but it still remained in negative territory.
- December 31, 2022: The operating profit margin further improved to -25.55%, showing a continued trend towards profitability as the company managed its expenses more efficiently.
- December 31, 2023: The company finally achieved a positive operating profit margin of 8.38%, indicating that it generated profit from its core operations after covering all operating expenses.
- December 31, 2024: The operating profit margin significantly improved to 32.59%, demonstrating even stronger profitability and efficiency in managing operating costs.

Overall, the data suggests that ADMA Biologics Inc experienced a challenging financial performance initially but gradually turned the situation around by enhancing operational efficiency and driving revenues to achieve positive operating profit margins in the later years.